Advertisement Fluxion signs distribution agreement with Labtech - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Fluxion signs distribution agreement with Labtech

Fluxion Biosciences, a provider of cellular analysis tools for use in life science research and drug discovery applications, has signed an exclusive distribution agreement with Labtech International, a provider of laboratory equipment, software and consumables.

Under this distribution agreement, Labtech will handle sales and service in the UK, Ireland and France of Fluxion’s BioFlux research tools for live cell image analysis in drug discovery.

Mark Atlas, director of sales at Fluxion, said: “We selected Labtech as our distribution partner in the UK, Ireland and France because of their proven, unique sales methods. Labtech has exceptional penetration of cell biology markets and their contacts are an ideal fit for our products.”